Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
It is with great regret that I inform you that Heart Failure 2020 & World Congress on Acute Heart Failure, scheduled for 23–26 May in Barcelona, is officially cancelled.
The leadership of the ESC and the Heart Failure Association (HFA) have been closely following the current health crisis. The spread of COVID-19 around the world and the necessity for healthcare professionals to deal with the epidemic in their hospitals has impacted the availability of both faculty and delegates. Indeed, many have already cancelled their plans to attend – and that number will only grow. In addition, the Spanish authorities have declared a state of emergency, while the Catalan government has imposed a total lockdown and severe travel bans.
As a result of these factors and our responsibility to protect the health of our faculty, delegates and staff, the HFA leadership has decided that cancelling Heart Failure 2020 is the only responsible course of action.
Should you have any queries, please refer to Heart Failure 2020 Cancellation - Your Questions Answered.
On behalf of the HFA Board, we convey our heartfelt wishes to you, your families and your patients in these difficult times.
ESC Heart Failure Association
Heart Failure 2020 & the World Congress on Acute Heart Failure is a unique opportunity for you to present your abstract, your case or Late-Breaking Science in front of an international audience of heart failure specialists.
Deadline is extended to 20 January 2020 noon Paris Time
You can submit your science from 2 to 31 March.
Your abstract, session slides or electronic poster will be published in:
Natalia Maroz-Vadalazhskaya, Belarus: “My primary motivation to send an abstract to Heart Failure Congress is to represent my country via my scientific work. The biggest advantage of attending the congress is the opportunity for open communication with top cardiologists.”
Mohammad El Tahlawi, Egypt: “I submitted an abstract for a chance to present my work in front of experts in this field, as well as many young researchers.”
Lidija Savic, Serbia: “I submitted my abstract in order to display results of my clinical research. Presenting a poster is a great opportunity to interact with colleagues from all over the world during coffee breaks in a relaxed and friendly atmosphere.”
Ercole Vellone, Italy: “Heart Failure Congress is an exciting and wonderful experience for researchers and clinicians aiming to improve their science and quality of care for their patients. My main motivation to submit an abstract was the great opportunity given by this congress to reach a prestigious international audience. Very few congresses give such a wide perspective on heart failure research, treatment and care.”
Narziev Bakhodir, Uzbekistan: “Presenting my abstract at the Heart Failure Congress gave me a great opportunity to record my research results. It helped me feel confident. Being one of the participants in the Heart Failure Congress helped me realize my hopes of reaching a great audience and exchanging ideas with experienced young investigators.”
Dr. Justo Sandino, Spain: “Presenting an abstract at the Heart Failure Congress is a win-win situation. It represents an opportunity to put out fresh, innovative ideas that increase our knowledge in our area of study. Likewise, it’s a marvellous channel for us young investigators to get experience; it is a great honour to present our findings and ideas at this prestigious congress.”
Mr. Alwin Zweerink, Netherlands: “For me, a relative greenhorn PhD student, the Heart Failure Congress means an opportunity to present my very first results. I was accepted to make a five-minute, moderated poster presentation. Considering the magnitude of the congress, I hope to reach a great audience and expect a critical appraisal of my work. Furthermore, I hope the presentation will attract other investigators of my research topic (cardiac resynchronization therapy) with whom I can exchange thoughts. From there, new ideas and collaborations can arise.”
Dr. Anura Malaweera, UK: “I am a clinical research fellow at the Royal Brompton Hospital in cardiology; exploring barriers to diagnosis and treatment of sleep disordered breathing (SDB) in cardiovascular disease. SDB or sleep apnoea is an important disorder, with up to 30-40% of heart failure patients suffering from it (this corresponds to ~320,000 patients in the UK!). A recent British Lung Foundation report suggested that 80% of these patients could be undiagnosed. Therefore, I believe the biggest benefit in presenting my work at the Heart Failure Congress is raising the profile of SDB in cardiovascular disease. Potentially, raising awareness may improve the diagnosis and treatment of these patients; so far we’ve only seen the tip of the iceberg!”
Miss Ariana Eloisa Foinquinos Marin, Germany: "The biggest benefit of presenting my abstract at the Heart Failure Congress is getting exposed to constructive discussions with an international and interdisciplinary panel. It is the perfect opportunity to get the input of experts, to exchange ideas with other young investigators and to network with possible cooperative partners who can contribute to the outcome of my project."
Dr. Irina Vishnevskaya, Ukraine: "The biggest benefit of presenting an abstract at the Heart Failure Congress is to be a part of the scientific world, to gain experience by communicating with colleagues from different countries and to improve my potential as a young doctor and scientist. There are opportunities to learn the latest trends in management of patients with heart failure, and then to successfully implement them into my practice routine. Presentation of my research results at this significant congress gives me confidence and helps me understand that I'm heading in the right direction."
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.